Related Experiment Videos
Factors predicting the diagnostic yield and intervention in obscure gastrointestinal bleeding investigated using
Reena Sidhu1, David S Sanders, Kapil Kapur
1Gastroenterology & Liver Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom. reena_sidhu@yahoo.com
Background:
In patients with obscure gastrointestinal bleeding (OGB), capsule endoscopy (CE) is the investigation of choice after negative conventional endoscopy. However, there is paucity of data on which clinical factors predict the ability of CE to detect pathology and alter management.
Aim:
To investigate clinical factors which predict a higher diagnostic yield and a change in management in patients presenting with OGB.
Methods:
Data was collected in patients with OGB for type of OGB [overt (OB) or iron deficiency anaemia (IDA)], co-morbidity, use of anticoagulants, transfusion dependence, subsequent CE diagnosis and follow up data. Factors that predicted a higher yield and a change in management were identified using logistic regression.
Results:
There were 427 patients (IDA 74%) with a mean age of 58 years (range 17-92).The diagnostic yield was 50% with a change in management in 30% of patients. The commonest finding was angiodysplasia in 52% of patients. There was no significant difference in the diagnostic yield between the two groups (OB: 56%, IDA 48%, p=0.15). On logistic regression, age (p=0.001), the use of warfarin (p=0.02) and liver co-morbidity (p=0.001) were significant factors which predicted a higher yield with CE. Factors which predicted a change in management included the presence of co-morbidity (p=0.02) and having a diagnosis of angiodysplasia on CE (p=0.001).
Conclusion:
This is a large series of CE in OGB. Increasing age, anti-coagulation and liver co-morbidity are significant predictors of a positive diagnostic yield whilst the presence of co-morbidity or a diagnosis of angiodysplasia may predict a change in management.
Related Concept Videos
Endoscopic Procedures III: Video Capsule Endoscopy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Lower GI Series: Barium Enema
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Endoscopic Procedures V: ERCP
Patient...